Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quantitative Gait Metrics to Assess and Predict Gross Motor Impairment in Young Children With Neurofibromatosis Type 1

NCT07564622 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT07564622
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07564622 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quantitative Gait Metrics to Assess and Predict Gross Motor Impairment in Young Children With Neurofibromatosis Type 1
Lead sponsor
NYU Langone Health
Phase
Observational
Overall status
Not yet recruiting
Start date
August 31, 2026
Completion date
January 31, 2031
Enrollment
56 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

neurofibromatosis type 1